Tower Research Capital (TRC)’s NLS Pharmaceutics NLSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-3
| Closed | -$110 | – | 6126 |
|
2023
Q2 | $110 | Buy |
+3
| New | +$110 | ﹤0.01% | 5785 |
|
2023
Q1 | – | Sell |
-3
| Closed | – | – | 6130 |
|
2022
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6205 |
|
2022
Q2 | – | Sell |
-92
| Closed | -$5K | – | 6374 |
|
2022
Q1 | $5K | Buy |
+92
| New | +$5K | ﹤0.01% | 5078 |
|
2021
Q2 | – | Sell |
-913
| Closed | -$148K | – | 5718 |
|
2021
Q1 | $148K | Buy |
+913
| New | +$148K | ﹤0.01% | 2262 |
|